These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 221575)

  • 1. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC; Rodrigues D; Igarashi T
    J Immunol; 1979 Apr; 122(4):1510-8. PubMed ID: 221575
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants.
    Igarashi T; Rodrigues D; Ting CC
    J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated anti-tumor response in the RLmale 1 system. I. T nature, H-2Dd involvement and antigenic specificity of the effector cells.
    Duprez V; Gomard E; Levy JP
    Eur J Immunol; 1978 Sep; 8(9):650-5. PubMed ID: 81780
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL; Forman J
    J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
    Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
    J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
    [No Abstract]   [Full Text] [Related]  

  • 8. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells.
    Lukacs K; Kurlander RJ
    J Immunol; 1989 Dec; 143(11):3731-6. PubMed ID: 2479688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
    Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
    J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.
    Okada M; Henney CS
    J Immunol; 1980 Aug; 125(2):850-7. PubMed ID: 6446579
    [No Abstract]   [Full Text] [Related]  

  • 12. H-2 restriction of adoptive immunotherapy of advanced tumors.
    Greenberg PD; Cheever MA; Fefer A
    J Immunol; 1981 Jun; 126(6):2100-3. PubMed ID: 6453154
    [No Abstract]   [Full Text] [Related]  

  • 13. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC; Rodrigues D
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral and cellular regulation of alloimmunity in pregnancy.
    Pavia CS; Stites DP
    J Immunol; 1979 Nov; 123(5):2194-200. PubMed ID: 158614
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of functional subpopulations of T lymphocytes. Initiator T lymphocytes recruit helper T cells for cytotoxic response.
    Livnat S; Corley RB
    Eur J Immunol; 1982 Apr; 12(4):313-9. PubMed ID: 6178602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH; Currie D; Hwang KM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS; Bennett M; Kumar V
    Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.